Effect of vascular endothelial related factors in patients with venous thromboembolism

J. Zhang (Yinchuan, Ningxia, China)

Source: International Congress 2017 – Pulmonary embolism
Session: Pulmonary embolism
Session type: Thematic Poster
Number: 2354
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Zhang (Yinchuan, Ningxia, China). Effect of vascular endothelial related factors in patients with venous thromboembolism. 2354

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors in patients with venous thromboembolism
Source: Eur Respir J 2002; 20: Suppl. 38, 239s
Year: 2002

Study on the risk factors of deep venous thrombosis in acute pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

The role of hereditary factors in venous thromboembolism
Source: Eur Respir J 2004; 24: Suppl. 48, 276s
Year: 2004

Analysis of risk factors in pulmonary thromboembolism
Source: Eur Respir J 2006; 28: Suppl. 50, 45s
Year: 2006

Venous thromboembolism and arterial atherosclerosis: a bidirectional association
Source: Virtual Congress 2020 – Cardiovascular morbidity and mortality after pulmonary embolism
Year: 2020


Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005


Genetic and acquired risk factors of venous thromboembolism
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=1
Year: 2004

Chronic thromboembolic pulmonary hypertension: role of medical therapy
Source: Eur Respir J 2013; 41: 985-990
Year: 2013



Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017

Treatment and prevention of cancer-associated venous thromboembolism
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021


Significance of certain predisponding genetic risk factors for venous thromboembolism
Source: Eur Respir J 2006; 28: Suppl. 50, 522s
Year: 2006

Increased platelet reactivity and thrombogenesis in pulmonary arterial hypertension subgroups
Source: Annual Congress 2009 - Pathobiology of pulmonary vascular diseases
Year: 2009


Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension
Source: Annual Congress 2004 - Pulmonary hypertension
Year: 2004


Peripheral endothelial dysfunction in patients with pulmonary artery hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 344s
Year: 2007

Endothelial progenitor cells in chronic thromboembolic pulmonary hypertension
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018



Importance of environmental factors in pulmonary embolism and pulmonary arterial hypertension
Source: International Congress 2019 – New trends in the management of pulmonary vascular disease
Year: 2019


Local inhibition of angiogenesis combined with repeated blood clot embolization induces chronic thromboembolic pulmonary hypertension in rabbits
Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension
Year: 2018




The incidence of venous thromboembolism recurrence in patients after first episode acute pulmonary embolism and related risk factors
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012